The regulatory landscapes for AI-enabled medical devices in the EU and US present distinct challenges and requirements, with the EU emphasizing comprehensive oversight through the AI Act and related regulations, while the US focuses on adaptability and patient outcomes under the FDA’s risk-based framework.
View full story…
Navigating AI Regulations in Medical Devices: EU vs. US Frameworks
